Clinical Trial Update: Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion [NA]

View source ↗

Summary

Clinical trial update reporting a completed study of intravitreal ranibizumab for neovascular age-related macular degeneration with posterior vitreomacular adhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Yonsei University | Conditions: Neovascular Age-related Macular Degeneration | NA | Status: COMPLETED